Adam A Witney
Overview
Explore the profile of Adam A Witney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1730
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seco-Hidalgo V, Witney A, Chico M, Vaca M, Arevalo A, Schuyler A, et al.
Sci Rep
. 2025 Feb;
15(1):5601.
PMID: 39955323
There are limited longitudinal data from non-industrialized settings on patterns and determinants of gut bacterial microbiota development in early childhood. We analysed epidemiological data and stool samples collected from 60...
2.
Vasiljevs S, Witney A, Baines D
Am J Physiol Lung Cell Mol Physiol
. 2023 Dec;
326(2):L125-L134.
PMID: 38084404
Cystic fibrosis-related diabetes (CFRD) affects 40%-50% of adults with CF and is associated with a decline in respiratory health. The microbial flora of the lung is known to change with...
3.
Timm J, Bateson A, Solanki P, Paleckyte A, Witney A, Rofael S, et al.
PLOS Glob Public Health
. 2023 Oct;
3(10):e0002283.
PMID: 37851685
Bedaquiline (B), pretomanid (Pa) and linezolid (L) are key components of new regimens for treating rifampicin-resistant tuberculosis (TB). However, there is limited information on the global prevalence of resistance to...
4.
Elton L, Kasaragod S, Donoghue H, Safar H, Amankwah P, Zumla A, et al.
Microb Genom
. 2023 Aug;
9(8).
PMID: 37526642
The bacillus Calmette-Guérin (BCG) vaccine has been in use for prevention of tuberculosis for over a century. It remains the only widely available tuberculosis vaccine and its protective efficacy has...
5.
Phillips L, Witney A, Furegato M, Laing K, Zhou L, Sadiq S
J Infect Dis
. 2023 May;
228(9):1179-1188.
PMID: 37216766
Background: Antimicrobial resistance (AMR) in Neisseria gonorrhoeae is a global health challenge. Limitations to AMR surveillance reporting, alongside reduction in culture-based susceptibility testing, has resulted in a need for rapid...
6.
Baede V, Gupta A, Knight G, Schouls L, Laing K, Tavakol M, et al.
Clin Microbiol Infect
. 2023 May;
29(9):1166-1173.
PMID: 37207981
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) infections impose a considerable burden on health systems, yet there is remarkable variation in the global incidence and epidemiology of MRSA. The MACOTRA consortium aimed...
7.
Lee S, Ferran E, Witney A, Ryu S, Kang H, Storey N, et al.
JAC Antimicrob Resist
. 2023 May;
5(3):dlad056.
PMID: 37193005
Background: WGS has significant potential to help tackle the major public health problem of TB. The Republic of Korea has the third highest rates of TB of all Organisation for...
8.
Lista M, Witney A, Nichols J, Davison A, Wilson H, Latham K, et al.
J Virol
. 2023 Mar;
97(3):e0184622.
PMID: 36916924
Cellular antiviral factors that recognize viral nucleic acid can inhibit virus replication. These include the zinc finger antiviral protein (ZAP), which recognizes high CpG dinucleotide content in viral RNA. Here,...
9.
Kloprogge F, Canseco J, Phee L, Sadouki Z, Kipper K, Witney A, et al.
Sci Rep
. 2022 Dec;
12(1):21429.
PMID: 36504241
Concentration dependency of phenotypic and genotypic isoniazid-rifampicin resistance emergence was investigated to obtain a mechanistic understanding on how anti-mycobacterial drugs facilitate the emergence of bacterial populations that survive throughout treatment....
10.
Karampatsas K, Faal A, Jaiteh M, Garcia-Perez I, Aller S, Shaw A, et al.
Medicine (Baltimore)
. 2022 Nov;
101(46):e31419.
PMID: 36401392
Microbiota composition in breast milk affects intestinal and respiratory microbiota colonization and the mucosal immune system's development in infants. The metabolomic content of breast milk is thought to interact with...